FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 67 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,036,909 | +550.9% | 233,538 | +317.8% | 0.00% | – |
| Q1 2023 | $159,315 | -48.9% | 55,900 | +30.6% | 0.00% | – |
| Q4 2022 | $311,584 | +2.5% | 42,800 | +13.8% | 0.00% | – |
| Q3 2022 | $304,000 | +85.4% | 37,600 | +12.2% | 0.00% | – |
| Q2 2022 | $164,000 | -67.9% | 33,500 | +55.1% | 0.00% | – |
| Q1 2022 | $511,000 | +33.8% | 21,600 | 0.0% | 0.00% | – |
| Q4 2021 | $382,000 | -18.4% | 21,600 | +30.1% | 0.00% | – |
| Q3 2021 | $468,000 | +169.0% | 16,600 | 0.0% | 0.00% | – |
| Q2 2021 | $174,000 | -5.9% | 16,600 | +5.7% | 0.00% | – |
| Q1 2021 | $185,000 | +0.5% | 15,700 | 0.0% | 0.00% | – |
| Q4 2020 | $184,000 | +47.2% | 15,700 | 0.0% | 0.00% | – |
| Q3 2020 | $125,000 | -54.4% | 15,700 | +4.7% | 0.00% | – |
| Q2 2020 | $274,000 | -91.9% | 15,000 | -97.1% | 0.00% | -100.0% |
| Q3 2019 | $3,382,000 | – | 509,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |